drugset / Trial / NCT05535803

Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells

NCT05535803 ↗

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The trial evaluates the safety and efficacy of the olfactory mucosa-derived mesenchymal stem cells based therapy for the patients with chronic laryngeal and tracheal stenosis

Timeline

Start
2021-06-01
Primary completion
2023-06-30
Completion
2023-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Olfactory mucosa-derived mesenchymal stem cells Cell therapy — Other